@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix chebi: . @prefix go: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 occursIn: obo:CLO_0008118, species:9606; rdf:object go:0008283; rdf:predicate belv:decreases; rdf:subject chebi:2917; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:atropine) -| bp(GOBP:\"cell proliferation\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_3; pav:version "20131211" . sub:_2 prov:value "Both the nicotinic antagonist mecamylamine and the muscarinic antagonist atropine inhibited growth of the H82 cell line but had little effect of the growth of the H69 cell line. Fig."; prov:wasQuotedFrom pubmed:12628474 . sub:_3 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12628474; prov:wasDerivedFrom beldoc:, sub:_2 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:59.831+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }